Enrofloxacin quick-release pellet and preparation method thereof

An enrofloxacin and immediate-release technology, which is applied in the field of enrofloxacin immediate-release pellets and its preparation, can solve the problems of poor oral palatability of enrofloxacin powder, increase the absorption and utilization time, and improve bioavailability , good therapeutic effect

Active Publication Date: 2019-08-02
RINGPU TIANJIN BIOLOGICAL PHARMA
View PDF12 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The invention designs and develops a kind of enrofloxacin quick-release pellets, which solves the problem of poor oral palatability of enrofloxac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enrofloxacin quick-release pellet and preparation method thereof
  • Enrofloxacin quick-release pellet and preparation method thereof
  • Enrofloxacin quick-release pellet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Table 1 10% content specification prescription

[0034] Name of raw material Addition g Enrofloxacin 10g (converted content) dextrin 2g Croscarmellose Sodium 2g sucrose 10g starch added to 90g 2% pvpk30 aqueous solution 60ml 10% hypromellose solution 50ml Titanium dioxide 2.0g polyethylene glycol 400 3.0g water 80ml

[0035] Preparation process

[0036] (1) Take enrofloxacin, dextrin, sucrose, starch and cross-linked sodium carboxymethyl cellulose and mix uniformly by prescription quantity;

[0037] (2) Weigh the pvpk30 component and throw it into purified water, and dissolve it by shearing for 15 minutes to obtain a binder solution;

[0038] (3) Put the powder in step 1 into the tank mixer machine, mix with the binder in step 2 to prepare soft material, and discharge;

[0039] (4) Add the soft material prepared in step 3 to the spherical extruder and spheronizer for 35 rotations and extrude,...

Embodiment 2

[0044] Table 2 20% content specification prescription

[0045] Name of raw material Addition g Enrofloxacin Hydrochloride 20g (converted content) lactose 40g Crospovidone 3g starch added to 95g water 70ml Acrylic resin emulsion (gastric disintegration) 2 silica 2.0g Triacetin 1.0g ethanol 80ml

[0046] Preparation process

[0047] (1) Take enrofloxacin hydrochloride, crospovidone, lactose and starch by prescription and mix evenly;

[0048] (2) Put the powder in step 1 into the tank mixer machine, add water and mix to prepare soft material, and discharge;

[0049] (3) Add the soft material prepared in step 2 to a spherical extruder for 45 rotations to extrude, and spheronize in a spheronizer at 600 rotations for 60 seconds, and dry the prepared ball cores in a fluidized bed at 60 degrees for 1 hour;

[0050] (4) Screen the dried material, get the material between 20 and 60 mesh, and set aside;

[0051] (5...

Embodiment 3

[0054] Table 3 10% content specification prescription

[0055] Name of raw material Addition g Enrofloxacin Hydrochloride 5g (converted content) Enrofloxacin 5 (converted content) microcrystalline cellulose 40g Low Substituted Hydroxypropyl Methyl Cellulose 3g starch added to 90g water 70ml Acrylic resin emulsion (gastric disintegration) 7g talcum powder 2.0g triethyl citrate 1.0g ethanol 80ml

[0056] Preparation process

[0057] (1) Take enrofloxacin, enrofloxacin hydrochloride, low-substituted hypromellose, microcrystalline cellulose and starch by weighing and mixing uniformly according to the prescription quantity;

[0058] (2) Put the powder in step 1 into the tank mixer machine, add water and mix to prepare soft material, and discharge;

[0059] (3) Add the soft material prepared in step 2 to a spherical extruder for 45 rotations to extrude, and spheronize in a spheronizer at 600 rotations for 6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an enrofloxacin quick-release pellet and relates to the field of veterinary medicines. The enrofloxacin quick-release pellet comprises the following components by weight percent: 10%-45% of enrofloxacin, 18%-86% of excipient, 1%-5% of disintegrating agent, 1%-2% of adhesive and 2%-30% of coating solution. The invention also relates to a preparation method for the enrofloxacin quick-release pellet. The enrofloxacin quick-release pellet is capable of covering the bitter taste of enrofloxacin and guaranteeing quick disintegration release of the preparation in gastrointestinal tracts. Compared with the preparation sold in the market, the enrofloxacin quick-release pellet has the advantages that the prescription is simplified, few sorts of ingredients are used, the quality problem of the preparation caused by uneven mixing of raw materials and ingredients in the preparation process is reduced, the preparation process is simple, the quality is stable and reliable andthe bioavailability of drugs in animal body is obviously increased.

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to veterinary drugs, in particular to an enrofloxacin quick-release pellet and a preparation method thereof. Background technique [0002] Enrofloxacin is a third-generation fluoroquinolone drug specially used for animals. It has the characteristics of broad antibacterial spectrum, strong bactericidal activity, wide distribution in the body, unique antibacterial effect, high bioavailability, small toxic and side effects, and no cross-resistance. It is still widely used in clinical veterinary medicine, favored by the veterinary field, and widely used in Europe, the United States and other countries. Clinically, it is mainly used to treat diseases caused by Gram-negative bacteria, mycoplasma, rickettsia and certain facultative anaerobic bacteria infections in pigs, cattle, sheep and other animals. At present, the pharmacokinetics of enrofloxacin has been widely studied, including p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/50A61K47/38A61K31/496A61P31/04
CPCA61K9/5042A61K31/496A61P31/04
Inventor 聂丽娜李雪娇曹春芳夏雪林刘爱玲李守军吴燕子
Owner RINGPU TIANJIN BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap